Hnu-D3 60K Chewable Tablet contains Vitamin D3 (Cholecalciferol) at a potent dosage of 60,000 IU per tablet, designed to address and prevent Vitamin D deficiency in patients requiring high-dose supplementation. Vitamin D3 plays a critical role in calcium and phosphorus homeostasis, promoting optimal bone mineralization and maintaining skeletal health. This formulation is indicated for the treatment of conditions such as rickets, osteomalacia, hypoparathyroidism, and other disorders associated with Vitamin D deficiency or insufficiency. The chewable tablet form facilitates ease of administration, particularly in patients with swallowing difficulties or pediatric populations. Upon ingestion, Vitamin D3 undergoes hepatic and renal hydroxylation to its active form, calcitriol, which enhances intestinal absorption of calcium and phosphate. Regular monitoring of serum calcium and Vitamin D levels is recommended during therapy to avoid hypercalcemia and toxicity. Hnu-D3 60K should be used under medical supervision, especially in individuals with hypercalcemia, hypervitaminosis D, or renal impairment. This high-dose supplement is typically administered weekly or monthly, depending on clinical assessment. It is essential to adhere to prescribed dosages and duration to achieve therapeutic efficacy while minimizing adverse effects.

Dosage & How to Use